Compare Stocks

→ Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BWAY BrainsWay	$4.76 -0.8%	$5.71	$1.38 ▼ $7.61	$79.21M	1.2	117,582 shs	30,879 shs
STIM Neuronetics	$3.49 -0.9%	$3.92	$1.03 ▼ $5.07	$104.63M	2.44	180,264 shs	44,573 shs
TMDI Titan Medical	$0.14 -26.3%	$0.23	$0.13 ▼ $1.20	$15.67M	2.36	4.83 million shs	7.71 million shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BWAY BrainsWay	-4.57%	+0.21%	-11.93%	-19.06%	+210.68%
STIM Neuronetics	-6.13%	-8.09%	-26.05%	+5.07%	+57.85%
TMDI Titan Medical	0.00%	0.00%	0.00%	0.00%	0.00%

These AI trades triggered this morning (545% return) (Ad)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BWAY BrainsWay	1.6731 of 5 stars	3.3	3.0	0.0	0.0	1.7	0.8	0.6
STIM Neuronetics	2.6374 of 5 stars	3.3	5.0	0.0	0.0	1.9	1.7	0.6
TMDI Titan Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BWAY BrainsWay	2.67	Moderate Buy	$7.00	47.06% Upside
STIM Neuronetics	2.50	Moderate Buy	$8.00	129.23% Upside
TMDI Titan Medical	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest TMDI, BWAY, and STIM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/26/2024	STIM Neuronetics	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
3/11/2024	BWAY BrainsWay	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
3/6/2024	STIM Neuronetics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$7.00 ➝ $8.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BWAY BrainsWay	$31.78M	2.49	N/A	N/A	$2.50 per share	1.90
STIM Neuronetics	$71.35M	1.47	N/A	N/A	$1.18 per share	2.96
TMDI Titan Medical	$20.09M	0.78	N/A	N/A	$0.32 per share	0.44

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BWAY BrainsWay	-$4.20M	-$0.13	N/A	59.50	N/A	-13.20%	-10.05%	-6.88%	5/8/2024 (Confirmed)
STIM Neuronetics	-$30.19M	-$1.07	N/A	N/A	N/A	-42.31%	-72.76%	-29.25%	5/7/2024 (Confirmed)
TMDI Titan Medical	-$14.86M	-$0.19	N/A	∞	N/A	N/A	-167.03%	-112.15%	N/A

Latest TMDI, BWAY, and STIM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2024	N/A	BWAY BrainsWay	-$0.02	N/A	+$0.02	N/A	N/A	N/A
5/7/2024	N/A	STIM Neuronetics	-$0.33	N/A	+$0.33	N/A	N/A	N/A
3/6/2024	12/31/2023	BWAY BrainsWay	-$0.03	-$0.01	+$0.02	N/A	$8.40 million	$9.03 million
3/5/2024	12/31/2023	STIM Neuronetics	-$0.26	-$0.19	+$0.07	-$0.19	$19.73 million	$20.31 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BWAY BrainsWay	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A
TMDI Titan Medical	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BWAY BrainsWay	N/A	5.68	5.30
STIM Neuronetics	1.73	4.73	4.33
TMDI Titan Medical	N/A	1.41	1.41

Ownership

Institutional Ownership

Company	Institutional Ownership
BWAY BrainsWay	30.11%
STIM Neuronetics	53.59%
TMDI Titan Medical	3.55%

Insider Ownership

Company	Insider Ownership
BWAY BrainsWay	19.00%
STIM Neuronetics	9.80%
TMDI Titan Medical	0.02%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BWAY BrainsWay	134	16.64 million	13.48 million	Not Optionable
STIM Neuronetics	203	29.98 million	27.04 million	Optionable
TMDI Titan Medical	49	111.95 million	111.93 million	Not Optionable

TMDI, BWAY, and STIM Headlines

Source	Headline
	TMD:CA Titan Medical Inc. seekingalpha.com - April 21 at 9:46 AM
	Titan Medical Inc.: Titan Medical Reports Fiscal Year 2023 Results finanznachrichten.de - April 1 at 8:49 AM
	Titan Medical signs deal to merge with Conavi Medical msn.com - March 21 at 4:35 AM
	Titan Medical Inc TMDIF morningstar.com - February 27 at 7:19 PM
	Perifery appoints Titan Data Solutions as authorised distributor advanced-television.com - February 13 at 8:31 AM
	Titan Medical Inc (TMD) investing.com - February 13 at 1:56 AM
	Vantage Titan 3T MRI Scanner from Toshiba news-medical.net - January 11 at 8:10 AM
	Attack on Titan: Hajime Isayama Will Create New Titan Story in 2024 comicbook.com - October 3 at 1:41 AM
	Five dead on Titan sub were 'true explorers' - OceanGate bbc.com - September 28 at 10:21 PM
	TMDIF Titan Medical Inc. seekingalpha.com - August 1 at 7:27 PM
	False claim Titan passenger was the vice chairman of the World Economic Forum \| Fact check usatoday.com - July 25 at 1:09 PM
	New details emerge about discovery of Titan submersible debris en.as.com - July 19 at 9:22 AM
	Destiny 2 best Titan build for PvE and PvP videogamer.com - July 18 at 7:32 AM
	Presumed human remains found in Titan sub debris bbc.co.uk - July 14 at 5:59 PM
	The Titan submersible imploded, killing all 5 on board asahi.com - July 9 at 10:09 AM
	Debris and 'Presumed Human Remains' Recovered From Titan Submersible msn.com - June 30 at 7:39 PM
	US Coast Guard says 'presumed human remains' found in wreckage of Titan submersible wbaltv.com - June 30 at 1:27 PM
	Titan Sub Tragedy: "Presumed Human Remains" and Mangled Debris Recovered From Atlantic Ocean eonline.com - June 29 at 9:37 AM
	Possible human remains recovered from Titan wreckage, Coast Guard says msn.com - June 28 at 11:36 PM
	Titan submersible tragedy could lead to lawsuits and regulatory changes, experts say yahoo.com - June 24 at 12:27 PM
	What happens during a catastrophic implosion? Titan submersible occupants likely died instantly winknews.com - June 24 at 1:01 AM
	The science that put the Titan submersible at risk of implosion ktbs.com - June 24 at 1:01 AM
	The Titan submersible: What could have gone wrong? msn.com - June 21 at 2:23 PM
	Report: Banging sounds heard during Titan submersible search, according to internal memo wlox.com - June 21 at 12:43 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BrainsWay

NASDAQ:BWAY

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Neuronetics

NASDAQ:STIM

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Titan Medical

NASDAQ:TMDI

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial